Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03749863 · ClinicalTrials.gov registry record · NA
Serial Platelet-Rich Plasma Injections for Vocal Fold Atrophy, Scar, and/or Sulcus Vocalis
A NA study of Dysphonia and Presbylarynx, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT03749863 is a NA study of Dysphonia and Presbylarynx that has completed, run by University of Southern California. The registered enrollment target is 14 participants, below the 60-participant average among 7 other Dysphonia trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03749863, a NA study of Dysphonia and Presbylarynx, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will investigate the safety and efficacy of four serial monthly vocal fold injections of platelet-rich plasma to treat dysphonia secondary to vocal fold atrophy, scar, and/or sulcus vocalis with glottal insufficiency
Conditions Studied
Interventions
- PROCEDURE Serial PRP injections
Study Locations (1)
California
- University of Southern California - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-02-18 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03749863
The ClinicalTrials.gov registry entry for NCT03749863 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 60-participant average among 7 other Dysphonia trials with a reported enrollment target (77% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Dysphonia appearing as the primary indexed condition, and to 1 intervention - of which Serial PRP injections is the first listed.
NCT03749863 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03749863 about?
NCT03749863 is a clinical study titled "Serial Platelet-Rich Plasma Injections for Vocal Fold Atrophy, Scar, and/or Sulcus Vocalis". This study will investigate the safety and efficacy of four serial monthly vocal fold injections of platelet-rich plasma to treat dysphonia secondary to vocal fold atrophy, scar, and/or sulcus vocalis with glottal insufficiency
What is the current status of trial NCT03749863?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2020-02-18. Estimated completion is 2022-09-30.
What conditions does trial NCT03749863 study?
This clinical trial studies the following conditions: Dysphonia, Presbylarynx, Atrophy; Larynx, Vocal Cord Atrophy, Presbylarynges.
What interventions are being tested in trial NCT03749863?
The interventions under investigation include: Serial PRP injections (PROCEDURE).
Who is sponsoring clinical trial NCT03749863?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03749863 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dysphonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes
RECRUITING · NA
-
Dysphonia, Distress, and Perceived Control: Technology Based Assessment and Intervention
COMPLETED · NA
-
Silk Protein Microparticle-based Filler for Injection Augmentation
COMPLETED · NA
-
Intensive Versus Traditional Voice Therapy
COMPLETED · NA
-
Translaryngeal Vibration for Hyperfunctional Voice Disorders
RECRUITING · Phase 3
-
The Mechanism Versus PPI Trial
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.